WHO ICTRP trial
A clinical study of the V540A vaccine in healthy adults (V540A-001)
CTIS2024-515785-14-00 · EU Clinical Trials Information System · Recruiting
Key facts
| Trial ID | CTIS2024-515785-14-00 |
|---|---|
| Public title | A clinical study of the V540A vaccine in healthy adults (V540A-001) |
| Scientific title | - V540A-001 |
| Primary sponsor | Merck Sharp & Dohme LLC |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): Yes Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | United States;Belgium |
| Conditions | Human Papilloma virus MedDRA version: 20.1Level: LLTClassification code: 10063001Term: Human papilloma virus infection Class: 10021881;Therapeutic area: Diseases [C] - Virus Diseases [C02] |
| Registration date | Aug 28, 2024 |
| Target size | 204 |
| Secondary IDs | U1111-1309-7794 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: